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Abstract  40 
 41 
In oocyte to embryo transition, the fertilized oocyte undergoes final maturation 42 
and the embryo genome is gradually activated during the first three cell 43 
divisions. How this transition is coordinated and which factors drive the 44 
processes in humans is largely unknown. Here we studied the role of the double 45 
homeodomain transcription factor DUX4 in regulating the human oocyte to 46 
embryo transition. DUX4 knockdown zygotes show delayed transcriptome 47 
reprogramming during the first three days after fertilization. Our combined 48 
experimental approaches allowed integrated analysis on the transcriptome, 49 
chromatin, and proteome data in human embryos or a DUX4 expressing human 50 
embryonic stem cell model. We conclude that DUX4 is a pioneering factor that 51 
regulates human oocyte to embryo transition through regulating oocyte mRNA 52 
degradation, as well as direct binding and activation of minor genome activation 53 
genes, and genomic repeat elements.  54 
 55 
 56 
 57 
 58 
 59 
 60 
 61 
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Mammalian pre-implantation development involves a series of coordinated processes, 63 
starting with oocyte to embryo transition (OET). OET is a major developmental 64 
reprogramming event from the oocyte to a totipotent embryo, involving fundamental 65 
changes in the epigenetic landscapes, degradation of maternal mRNAs, and 66 
embryonic genome activation (EGA)1. In humans, the major EGA takes place by the 67 
8-cell stage2-4. Minor EGA genes are upregulated in the human 4-cell embryos where 68 
they subsequently induce genes upregulated at the major EGA3. Until now, most 69 
studies focusing on human EGA have concentrated on the genes that are expressed in 70 
the cleavage stage (2-cell, 4-cell, and 8-cell) embryos3,5 and set the stage for the 71 
forthcoming lineage commitment6,7. How OET and EGA are orchestrated in the 72 
human embryos and which genes act as pioneers remain poorly understood.  73 
 74 
The conserved double homeodomain transcription factor DUX4 is expressed in early 75 
human embryos8-10. It represents a plausible candidate to regulate the OET in humans, 76 
given its capacity to activate EGA-related genes and the genomic repeat elements8,9. 77 
In this work we have used a combination of methods to investigate DUX4 in the 78 
course of early human development. Our data highlight DUX4 mRNA upregulation 79 
already in the zygotes followed by down-regulation within the next cell division. 80 
Abundant cytoplasmic and nuclear DUX4 protein was apparent only during the first 81 
two days of development. Our in-depth characterisation of DUX4 in the human 82 
embryos suggested that it is not required for survival of the human embryos during 83 
the first three days of development but that DUX4 regulates OET in the human. 84 
siRNA silencing of DUX4 in zygotes delayed oocyte mRNA degradation. Our 85 
comprehensive analysis of transcriptome and chromatin data in human embryos or 86 
DUX4 expressing cell lines suggested that DUX4 opens up chromatin through direct 87 
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activation of the retroelements and unannotated genomic regions. Our protein 88 
interaction data demonstrated that DUX4 interacts with transcriptional mediators, 89 
chromatin modifiers, and ubiquitinases expressed in the human oocytes and early 90 
embryos. We conclude that DUX4 regulates different aspects of the OET in humans 91 
by affecting mRNA degradation, transcriptional regulation and chromatin structure.  92 
 93 
 94 
 95 
 96 
 97 
 98 
 99 
 100 
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Results  102 
DUX4 is transiently expressed immediately after fertilization  103 
We first measured DUX4 mRNA levels in human MII oocytes (N=20), zygotes 104 
(N=59), and cleavage embryos (2-cell, N=4; 4-cell, N=14; 8-cell, N=15). We found 105 
significant DUX4 upregulation in the zygotes, while few transcripts were found in the 106 
MII oocytes or the cleavage embryos10-13 (Fig. 1a). The expression of the DUX is 107 
evolutionary conserved as shown by stage-specific expression in mouse, bovine, and 108 
non-human primates14. We stained embryos with a monoclonal antibody targeting the 109 
DUX4 protein and detected cytoplasmic DUX4 in the zygotes and all cleavage 110 
embryos although less in 8-cell embryos (Fig. 1b). DUX4 protein was abundantly 111 
present in the nuclei of the 2- and 4-cell embryos whereas nuclei of the 8-cell 112 
embryos were mostly negative (Fig. 1b). In a single early 8-cell stage embryo there 113 
was high variability in the nuclear DUX4 staining, consistent with a snapshot of on-114 
going degradation. We quantified nuclear DUX4 intensities in 3D and normalized 115 
them to the cytoplasmic DUX4 intensities and found variable but increasing nuclear 116 
signal from the zygotes up to the 4-cell embryos, while nuclear DUX4 was low or 117 
absent in the 8-cell embryos (Fig 1c). These results demonstrated that DUX4 118 
transcription takes place immediately after fertilisation and is followed by 119 
cytoplasmic and nuclear localisation of the DUX4 protein during the first two days of 120 
human embryo development.  121 
 122 
DUX4 protein may form a relatively stable structure even when not bound to DNA  123 
Given predominant DUX4 protein presence in the cytoplasm of the embryos as well 124 
as stage-specific nuclear localization, we analysed the structural features of DUX4 125 
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(Fig. 2). Human DUX4 comprises two homeodomains (HD1: residues 19-81; and 126 
HD2: 94-153; UniProt numbering), an intrinsically disordered region (IDR: 154-370) 127 
and a C-terminal domain (residues 371-424; Fig. 2a). A stretch of hydrophobic 128 
residues (308-323) within IDR is conserved in primates and could have a regulatory 129 
role by interacting with other transcription co-regulators or masking the C-terminal 130 
domain from solvent when no interacting partners are present. The C-terminal domain 131 
is predicted to have two structurally ordered and evolutionarily conserved regions: 132 
residues 371-387 and residues 414-423 (Fig. 2a). As a secondary structure the C-133 
terminal domain is predicted to contain three alpha helices and may form a stable fold 134 
similar to that revealed by NMR for the Pax8 paired box domain (PDB: 2K27;15). We 135 
found a nine amino acid transactivation domain (9aaTAD) located at the C-terminal 136 
domain (371-379), also recently reported by Mitsuhashi et al.16. This motif is also 137 
present in the PRD-like homeoprotein LEUTX17 and might be recognized by other 138 
proteins involved in the regulation of transcription, similar to the 9aaTAD motif of 139 
the MLL that interacts with the cAMP-response element binding protein, a 140 
transcriptional co-activator18. 141 
 142 
In the crystal structure of DUX4 (PDB: 6E8C;19) HD1 and HD2 bind DNA in a 143 
symmetric manner (Fig. 2b). Residue R21, located at the N-terminal loop of HD1, 144 
interacts with the residues I121, E135 and Q139 of HD2 and, equivalently, R96 145 
located at the N-terminal arm of the HD2 interacts with the residues I46, E60 and Q64 146 
of HD1 (Fig. 2b, c, d). Moreover, the main-chain carbonyl groups of G19 of HD1 and 147 
G94 of HD2 respectively form a hydrogen bond with the main-chain nitrogen atom of 148 
I121 of HD2 and I46 of HD1. We next asked whether these residues are conserved 149 
within the DUX family of homeoproteins and within primates (Fig. 2e): based on our 150 
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sequence alignment, residues equivalent to G19, R21, I46, E60, Q64, G94, R96, I121, 151 
E135 and Q139 of DUX4 are highly conserved. Interestingly, the residues G19, R21, 152 
I46, E60, Q64, G94, R96, I121, E135 and Q139 of DUX4 (Fig. 2c,d) are not directly 153 
involved in DNA binding, which prompted us to speculate that these residues could 154 
be important for locking HD1 and HD2 together as a unit before DNA binding, a 155 
hypothesis, which we further tested using molecular dynamics (MD) simulations. 156 
  157 
Based on MD simulations and the RMSD among snapshots made every 10 ps (Fig. 158 
2f), the DUX4 HD2-DNA complex appeared the most stable complex (average 159 
RMSD over backbone atoms of 1.73 Å), followed by DUX4-DNA (1.77 Å) and 160 
DUX4 HD1-DNA complex (2.3 Å). The DNA-free DUX4 HD1-HD2 structure (4.0 161 
Å) was the least stabile yet the interactions between HD1 and HD2 were maintained 162 
over the 100 ns simulation. Indeed, ionic interactions between R96 of HD2 and E50 163 
and E60 of HD1 seem to be fundamental for the stability of the double HD structure 164 
of DUX4: the electrostatic interactions/hydrogen bonds between R96 and E60 were 165 
present during 92% of the simulation time. Additional stabilizing interactions between 166 
the two HDs also take place between R21 (HD1) and E135 (HD2), and R22 (HD1) 167 
and E125 (HD2). While these charged interactions hold the two HDs together, the 168 
intermediate linker loop imparts flexibility, which could be vital to accommodate 169 
DNA once DUX4 enters the nucleus and locates its binding motif. Even with bound 170 
DNA, the linker loop fluctuates more relative to HD1 and HD2, as observed from the 171 
RMSF values for the CA atoms of residues of the DUX4-DNA structure (Fig. 2g). 172 
 173 
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 9 
DUX4 protein interacts with transcriptional mediators and chromatin modifiers  174 
Abundant nuclear and cytoplasmic DUX4 in the human embryos and the modelled 175 
stable structure of the DUX4 when not bound to DNA suggested that DUX4 might 176 
have functions beyond DNA binding. To study this, we applied a recently published 177 
MAC-tag method to identify DUX4 protein-to-protein interactions20,21. We identified 178 
altogether 158 BioID and 43 AP-MS high-confidence DUX4 interactions, out of 179 
which 19 appeared in both datasets (FDR < 0.05, corresponding to > 0.73 SAINT 180 
Score). Single BioID interactions and AP-MS interactions together with the 181 
interactions that appeared in both data sets, based on the scored frequency of 182 
interaction with DUX4, are shown in Fig 3a. We concentrated on the DUX4 183 
interacting proteins that scored above the median value (Fig 3b). Overrepresentation 184 
Enrichment Analysis (ORA) of protein pathway markers (Reactome, KEGG) showed 185 
significant enrichment (p < 0.05, FDR < 0.01) of markers linked to generic 186 
transcription and ‘RNA Polymerase II Transcription’, ‘Chromatin organization’ and 187 
‘Chromatin modifying enzymes’. Comparing our list of genes to protein complex 188 
databases such as ComplexPortal and Corum using Fisher’s Exact Test yielded 189 
significant overrepresentation of several variants of the SWI/SNF ATP-dependent 190 
chromatin remodelling complex, Core mediator complex, NSL histone 191 
acetyltransferase complex, SRCAP histone exchanging complex and the NuA4 192 
histone acetyltransferase complex (p < 0.05, FDR 0.01) (Fig. 3b).  There were 28 193 
DUX4 interacting proteins classified as RNA binding (GO:0003723) and 19 out of 194 
these were linked to spliceosome and pre-mRNA-splicing. In the protein complex 195 
database Corum, DUX4 interactors were significantly overrepresented in the 196 
Spliceosome, with 10 interactors comprising 7% of the whole complex.  In addition, 197 
we found six DUX4 interacting proteins (ZSCAN4, ZSCAN5C, ZSCAN5D, RFPLA, 198 
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RFPLB, RNF8, PTOV1, and MB3LB) that have not appeared in the analyses of other 199 
transcription factors.  As the protein interaction assay was run in a non-embryonic cell 200 
line (HEK), we next studied which of the identified DUX4 interacting proteins are 201 
expressed by human oocytes or embryos3,11. Importantly, the vast majority of the 202 
genes coding for the DUX4 interacting proteins were expressed in oocytes (maternal 203 
genes), embryos, or both. These results suggested that DUX4 could potentially 204 
regulate maternal and embryonic proteins in the cytoplasm and nucleus during the 205 
OET.  206 
 207 
Knock-down of DUX4 in human zygotes leads to dysregulation of the maternal 208 
transcriptome  209 
We next asked how DUX4 regulates the OET and early human embryo development. 210 
We microinjected either DUX4 targeting siRNA (siDUX4) or control siRNA 211 
(siCTRL) together with GAP-GFP mRNA to triploid human zygotes and followed 212 
their development for 48 h after the microinjections, until the third day of 213 
development (Fig 4a). 18 h after microinjection, GAP-GFP protein was expressed in 214 
all embryos, confirming successful microinjections. Staining for the DUX4 protein 215 
was very faint or absent in the siDUX4 embryos but strongly positive in the siCTRL 216 
embryos 24 h after microinjection, showing that the DUX4 targeting siRNA 217 
efficiently down-regulated DUX4 (Fig 4b). The cells from the embryos were 218 
collected 48 h after microinjections for single-cell-tagged reverse transcription RNA 219 
sequencing (STRT RNA-seq22,23), which detects the transcript far 5’-ends (TFEs). 220 
siDUX4 embryos did not arrest during the experiment by live imaging follow-up, but 221 
their transcriptome was dysregulated in comparison to that of the siCTRL embryos. A 222 
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number of transcripts downregulated in the siCTRL appeared enriched in the siDUX4 223 
embryos (Fig. 4c). In order to study how the siDUX4 enriched transcripts typically 224 
behave during the first three days of development, we next compared siDUX4 and 225 
siCTRL embryos to our published gene expression data set3,10 on human MII oocytes, 226 
zygotes, and cleavage cells. These analyses further confirmed that a large number of 227 
TFEs that remained enriched in the siDUX4 embryos were typically downregulated 228 
between the oocytes and the 4-cell embryos (Fig 4d), the zygotes and the 4-cell 229 
embryos (Fig 4e), and the 4-cell and 8-cell embryos (Fig 4f), indicating delayed 230 
degradation of the maternal transcripts. Gene expression enrichment analysis using 231 
TopAnat24 for the altogether 91 genes enriched in siDUX4 embryos resulted in terms 232 
such as ‘female germ cell’ and ‘oocyte’, in agreement with non-degraded maternal 233 
transcripts. As shown for the siDUX4 enriched gene set, a number of well-known 234 
maternal genes such as GDF9, ZP1, ZP2, ZP3, KHDC3L, WEE2, NPM3, TUBB8, and 235 
RERE failed to downregulate (Fig. 4g), demonstrating that the OET remained 236 
incomplete after DUX4 abolishment in human zygotes.  237 
 238 
DUX4 directly activates the minor EGA genes and a number of unannotated regions 239 
We next generated two TetOn-DUX4 human embryonic stem cell (hESC) lines 240 
expressing DUX4-ires-EmGFP under doxycycline, and studied the effects of DUX4 241 
on the activity and accessibility of the genome (Fig 5a). DUX4 mRNA (Fig 5b) and 242 
protein (Fig 5c) expression promptly followed doxycycline induction and the known 243 
DUX4 target genes ZSCAN4 and TRIM48 followed the induction with slight delay 244 
(Fig 5b). We performed bulk RNA-seq using STRT RNA-seq methods and the data 245 
analysis of the sorted EmGFP+ DUX4 expressing cells showed roughly equal 246 
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numbers of up- and downregulated TFEs (Fig 5d). Notably, the majority of the 247 
upregulated TFEs were mapped to unannotated genomic regions, whereas the 248 
downregulated TFEs were mapped to protein coding regions (Fig 5d). The known 249 
target genes of DUX4, i.e., ZSCAN4, LEUTX and TRIM48 were significantly 250 
upregulated in the EmGFP+ cells (Fig 5e). Downregulated protein-coding TFEs 251 
included a number of ribosomal genes and genes maintaining pluripotency. This is in 252 
agreement with previous findings showing that DUX4 downregulates some 253 
pluripotency markers25. We integrated the data from our RNA-seq and published 254 
DUX4 ChIP-seq analysis26,27 and found that out of the 32 minor EGA genes induced 255 
in 4-cell embryos3, 23 were induced in the EmGFP+ cells and 17 out of these 256 
overlapped with DUX4 binding sites. This suggested that DUX4 can induce the 257 
majority of the minor EGA-related genes (Fig 5f). We also identified three previously 258 
unannotated DUX4 targets KHDC1 pseudogene 1 (FE463525; Fig 5e and 6a), RING-259 
finger type E3 ubiquitin ligase (FE533694; Fig 5e and 6b), and RING-finger domain 260 
protein 4.2 (FE130507; Fig 5e and 6c) that were induced in 4-cell embryos3, were 261 
upregulated by DUX4, and overlapped with DUX4 binding sites. We cloned novel 262 
DUX4 target transcripts from a cDNA pool of human day 4 embryos, confirming 263 
their presence in early human cleavage embryos (Fig 6). On the other hand, out of the 264 
129 major EGA genes upregulated in 8-cell human embryos3, 14 were upregulated by 265 
DUX4 and interestingly, 33 were downregulated (Fig 5f). These data suggested that 266 
DUX4 could upregulate some major EGA genes, but that most of them are likely 267 
activated by the minor EGA genes (such as LEUTX28), and that DUX4 might also 268 
negatively regulate major EGA genes. DUX4-induced TFEs were highly enriched 269 
with DUX4 binding sites26,27 (Fig 5g), and the most highly enriched motif in the 270 
DUX4-induced TFEs was similar to the known DUX4 motif29 (Fig 5h). Furthermore, 271 
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these TFEs were remarkably overrepresented with the DUX4 binding sites among 272 
hundreds of transcription factors (Fig 5i).  273 
 274 
Ectopic DUX4 expression causes chromatin opening at ERVL-MaLR elements similar 275 
to 2-cell human embryos 276 
We next integrated STRT RNA-seq and ATAC-seq data from EmGFP +/- sorted 277 
TetOn-Dux4 hESC. DUX4 expression lead to consistent modifications in chromatin 278 
accessibility across all studied clones (Fig 7a). The transcriptionally upregulated TFEs 279 
correlated with more accessible (gained) genomic regions in the DUX4 induced cells 280 
while the correlation was less obvious for the downregulated TFEs and less accessible 281 
(lost) chromatin (Fig 7a). We found that the gained chromatin regions correlated with 282 
upregulated TFEs and lost chromatin regions correlated with downregulated TFEs 283 
(Fig 7b), likely implying that the transcriptional downregulation induced by DUX4 284 
expression is faster than the nucleosome-mediated closing of the chromatin (Fig 7a 285 
and b). We then asked how DUX4 expression modified openness of the different 286 
regions of the chromatin. In general, DUX4 rapidly caused chromatin remodelling, 287 
especially chromatin opening, far from transcription start sites (TSS), demonstrating 288 
that the TSSs seem to be less targeted by the DUX4 expression than other genomic 289 
regions (Fig 7c). We next focused on the ATAC-gained chromatin sites. These 290 
chromatin regions were remarkably enriched with DUX4 binding sites compared with 291 
unchanged regions (P<2.2e-16). Out of the ATAC-gained chromatin sites, 48.9% 292 
overlapped with ERVL-MaLR elements and they were significantly enriched for the 293 
DUX4 binding sites compared with non ERVL-MaLR overlapping sites (55.8% P < 294 
2.2e-16) (Fig. 7d). The ATAC-gained ERVL-MaLR regions remarkably overlapped 295 
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with the open chromatin regions found in 2-cell human embryos30 (Fig. 7e). Out of 296 
the DUX4 induced gained chromatin regions that overlapped with those of the 2-cell 297 
embryos, upregulated by DUX4 induction, and overlapped with DUX4 binding sites, 298 
76.7% were unannotated. Only few protein-coding genes, for instance ZSCAN4 and 299 
the transcriptional and chromatin regulators KDM5B (JARID1B) and ZNF296 were 300 
included. These results show that DUX4 directly binds ERVL-MaLR elements and 301 
converts the chromatin landscape of the hESCs towards that of the human 2-cell 302 
embryos. These data also suggest that DUX4 largely functions through yet 303 
unannotated genomic regions.  304 
  305 
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Discussion  306 
The OET, including fertilization and activation of the oocyte to totipotent blastomeres 307 
and subsequent EGA, gradually sets the stage for embryo development31-33. How the 308 
OET is orchestrated in human and which factors are the main drivers are still poorly 309 
known. One of the potential candidates driving the OET in human embryos is DUX4. 310 
Our data here show that DUX4 transcripts appear immediately after fertilisation and 311 
are downregulated rapidly following the first and the second cleavage divisions. The 312 
origin of DUX4 transcripts is still unclear. It could be one of the maternal dormant 313 
RNAs, supported by the fact that DUX4 was absent in the majority of the oocytes but 314 
was significantly induced in the zygotes. Dormant maternal RNAs are stored in the 315 
oocytes as deadenylated transcripts and they are polyadenylated and translated only 316 
after resumption of meiosis or after fertilisation34. The increasing nuclear DUX4 317 
protein intensity from zygotes to 4-cell embryos and its disappearance in the nuclei of 318 
8-cell embryos suggested that DUX4 can modify transcriptome and chromatin of the 319 
embryos already before the genome activation takes place. Detailed mechanisms of 320 
DUX4 protein degradation in the 8-cell embryos remain to be further investigated; 321 
however, DUX4 upregulated and interacted with several protein ubiquitinases, such 322 
as TRIM48, a well-known DUX4 target gene. We also identified two previously 323 
unannotated and possibly embryo-specific putative RING-finger type E3 ubiquitin 324 
ligases that were expressed in early human embryos and induced by DUX4. The 325 
putative ubiquitinases RFPLA (RFPL4A) and RFPLB (RFPL4B) regulate protein 326 
degradation in germ cells35,36. Another ubiquitin-ligase, RNF114, was recently shown 327 
to be essential for the OET in the mouse37. Taken together, our data suggested that 328 
DUX4 induces expression of ubiquitin ligases and also interacts with ubiquitinases, 329 
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possibly regulating the presence of DUX4 itself as well as general proteome during 330 
OET.  331 
 332 
Knock-down of DUX4 in the human zygotes did not cause mitotic arrest during the 2-333 
day experiment, in agreement with recent findings on Dux in mouse embryos where a 334 
minority of embryos may proceed until blastocyst stage8,38,39. In the mouse Dux-/- 335 
embryos, around 30% of the EGA transcripts that should be upregulated were 336 
downregulated39, while in the human DUX4 knock-down embryos, many of the 337 
maternal, normally downregulated genes remained unchanged, suggesting that 338 
Dux/DUX4 alone is sufficient for neither the OET nor the EGA. Another candidate 339 
gene regulating OET is PLAG140. De novo PLAG1 binding site is found in the EGA 340 
genes in the human embryos, and the phenotype of Plag1+/- mice lacking the 341 
maternal Plag1 allele show enriched expression of maternal transcripts at the 2-cell 342 
stage, when major EGA occurs in the mouse. The question remains how DUX4, 343 
together with other factors such as PLAG1, coordinates regulation of the maternal and 344 
EGA transcripts in human and which yet unnamed genes might be involved in the 345 
OET in human.  346 
 347 
Ectopic expression of DUX4 in the hESC caused opening of the chromatin regions 348 
outside of TSSs, largely at ERVL-MaLR elements. Dux binding at Mervl loci drives 349 
chromatin reorganisation at Mervl loci in the mouse 2-cell embryo-like cells, and 350 
chromatin organisation during early mouse development is a consequence of the 351 
Mervl integration41. Human 2-cell-like cells have not been established by now, but 352 
importantly, in our experiments binding of the DUX4 at ERVL-MaLR elements14 353 
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could modify chromatin towards embryo-like stage even in the hESCs. Long terminal 354 
repeat elements abundantly present in the genome have been suggested as key 355 
elements contributing to the OET, when major epigenetic and chromatin changes take 356 
place42. Our integrated analysis on chromatin openness and transcriptional regulation, 357 
together with the DUX4 ChIP-seq data26,27 demonstrated that DUX4 regulates several 358 
transcripts and the corresponding genomic loci coding for chromatin modifiers and 359 
epigenetic regulators, as also suggested by Liu et al.43. Taken together, our data 360 
indicate that DUX4 alone is not a sufficient inducer for the first three days of human 361 
embryo development but that it regulates the OET by regulating maternal RNA 362 
degradation, EGA genes, and repetitive elements, all of which have been shown to be 363 
crucial for the successful OET in organisms other than human. In addition to 364 
regulating genetic elements by DNA-binding, DUX4 may regulate the proteome by 365 
inducing ubiquitination pathway genes during the OET in human.  366 
 367 
 368 
 369 
 370 
  371 
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Online methods  372 
 373 
Human pre-implantation embryos for single cell RNA-sequencing using STRT method  374 
We analysed single cell RNA-sequencing data from Töhönen et al.3 for MII oocytes 375 
(N=20), zygotes (N=59), 2-cell (N=4), 4-cell (N=15) and 8-cell (N=14) embryos.  376 
For the DUX4 knockdown experiment 18 siCTRL cells (N=2) and 18 siDUX4 cells 377 
(N=3) were analysed. The embryos were incubated in Ca2+/Mg2+ -free culture 378 
medium (Biopsy Medium, Origio) at 37°C heated stage for separation of the cells. 379 
Individuals cells were briefly rinsed in Ca2+/Mg2+ -free PBS and placed directly in 380 
lysis buffer (5mM Tris-HCl, pH 7.0 (LifeTechnologies); 5mM DTT (Thermo 381 
Scientific), 0.02 % Tx100 (Fisher Scientific); 0.5 U/µl Ribolock RNAse inhibitor 382 
(ThermoFisher)). The library was prepared according to the published protocol3,22,44. 383 
The amplified libraries were sequenced on the Illumina HiSeq 2000 instrument.  384 
 385 
Bulk RNA-sequencing using STRT method 386 
Total RNA was isolated from the FAC-sorted DUX4-TetOn hESCs using the 387 
RNAqueous Total RNA Isolation Kit (AM1912; ThermoFisherScientific). 20ng of 388 
total RNA from each sample was used for library preparations. The libraries were 389 
prepared using the STRT method as above, with minor modifications. Briefly, RNA 390 
samples were placed in a 48-well plate in which a universal primer, template-391 
switching oligos, and a well-specific 8-bp barcode sequence (for sample 392 
identification) were added to each well23,45. The synthesized cDNAs from the samples 393 
were then pooled into one library and amplified by single-primer PCR with the 394 
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universal primer sequence. The resulting amplified library was then sequenced using 395 
the Illumina NextSeq 500 instrument.  396 
 397 
Preprocess of raw STRT RNAseq reads 398 
The sequenced STRT raw reads were processed by STRTprep23, v3dev branch 399 
91a62d2 commit at https://github.com/shka/STRTprep/tree/v3dev. The processed 400 
nonredundant reads were aligned to hg19 human reference genome sequences, ERCC 401 
spike-in sequences and human ribosomal DNA unit (GenBank: U13369) with RefSeq 402 
transcript alignments as a guide of exon junctions. For gene-based statistics, uniquely 403 
mapped reads within (i) the 5’-UTR or the proximal upstream (up to 500 bp) of the 404 
RefSeq protein coding genes, and (ii) within the first 50 bp of spike-in sequences, 405 
were counted. For TFE-based statistics, the mapped reads were assembled according 406 
to the alignments, and uniquely mapped reads within the first exons of the assembled 407 
transcripts were counted, as described in Töhönen et al 20153.  408 
 409 
Downstream STRT RNA-sequencing data analysis 410 
Differentially expressed genes and TFEs required significantly different tendency on 411 
the expression levels between two groups (q-value < 0.05), and significantly larger 412 
variation than the technical variation (adjusted p-value < 0.05 by BH correction). The 413 
former tendency was tested by the R package SAMstrt v0.99.045, and the latter 414 
variation (fluctuation) was estimated based on gene-to-spikein (or TFE-to-spikein) 415 
ratios in the squared coefficient of variation, described in Supplementary Text 1 of 416 
Krjutskov et al. 201623. The minimum value but non-zero was added to all the 417 
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normalized read counts and then the counts were divided by the minimum value so 418 
that the logarithm of zero counts become zero. Enrichment analysis of anatomical 419 
terms for the list of upregulated genes by siDUX4 was performed using the TopAnat24 420 
(https://bgee.org/?page=top_anat). All human genes in the Bgee database were used 421 
as background. STRT data of human early embryo were obtained from Töhönen et al. 422 
2015 and 20173,10 and were overlapped with TFEs using the intersectBed function 423 
from BEDTools46 (v2.27.1). DUX4 ChIP-seq data was obtained from GSE3383826 424 
and scores around the FEs were calculated with computeMatrix and visualized with 425 
plotProfile from deepTools47 (v3.1.3). Motif enrichment was analyzed using the 426 
command findMotifsGenome.pl from HOMER48 (v4.10.3) with the option “-size -427 
300,100”. Enrichment analysis with publicly available ChIP-seq datasets was 428 
conducted with ChIP-Atlas49 (http://chip-atlas.org). A total of 7,216 human 429 
transcription factor ChIP-seq datasets which had more than 500 peaks were analyzed. 430 
Fold enrichment was calculated as (the number of ChIP-seq peaks overlapping with 431 
upregulated TFEs / the number of upregulated TFEs) / (the number of ChIP-seq peaks 432 
overlapping with all TFEs / the number of all TFEs). P-values were calculated with 433 
Fisher’s exact test and Q-values were calculated with the Benjamini & Hochberg 434 
method. After excluding the TFEs annotated on ribosomal DNA, 6,425 upregulated 435 
TFEs were used as foreground and 109,624 all the detected TFEs were used as 436 
background both in the motif and ChIP-seq enrichment analysis. 437 
 438 
Human ESC culture  439 
hESC lines H1 (WA01) and H9 (WA09) were purchased from WiCell. The hESCs 440 
were maintained on Geltrex-coated tissue culture dishes in Essential 8 culture medium 441 
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and passaged every three to five days by incubation with 0.5 mM EDTA (all from 442 
Thermo Fisher Scientific).  443 
 444 
Plasmid construction  445 
The full-length DUX4 (NM_001293798.2) was synthesized and cloned between the 446 
SalI and BamHI sites of the pB-tight-hMAFA-ires-EmGFP-pA-PGK-Puro vector (a 447 
kind gift from Diego Balboa, Biomedicum Stem Cell Centre) at GenScript (Genscript, 448 
NJ, USA).  449 
 450 
Doxycycline-inducible DUX4 expressing human ESCs  451 
The hESCs were incubated with StemPro Accutase (Thermo Fisher Scientific) until 452 
the edges of the colonies started to curl up. The Accutase was aspirated and the cells 453 
were gently detached in cold 5% FBS (Thermo Fisher Scientific) -PBS (Corning) and 454 
counted. One million cells were centrifuged at 800rpm for 5 min and the pellet was 455 
transferred into 120 µl of R-buffer containing 1 µg of pB-tight-DUX4-ires-EmGFP-456 
pA-PGK-Puro, 0.5 µg of pBASE and 0.5 µg of rtTA-M2-IN plasmids. 100 µl of the 457 
cell-plasmid suspension was electroporated with two pulses of 1100 V, 20 ms pulse 458 
width, using Neon Transfection system. The electroporated cells were plated on 459 
Geltrex-coated dishes in Essential 8 medium with 10 µM ROCK inhibitor Y27632 460 
(Peprotech). Fresh Essential 8 medium without ROCK-inhibitor was changed to the 461 
cells on the day following the electroporation. The cells were selected with 462 
Puromycin at 0.3 µg/mL.  The TetOn-DUX4 hESC clones were picked manually on 463 
Geltrex-coated 96-well plates, expanded and selected again with Puromycin. 464 
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Appearance of the EmGFP reporter protein was tested using Doxycycline at 465 
concentrations ranging from 0.2 µg/ml to 1.0 µg/ml and detected using EVOS FL Cell 466 
imaging system (Thermo Fisher Scientific). When indicated for the experiments 467 
presented in this paper, the EmGFP+ DUX4 expressing hESC clones had been treated 468 
with 1µg/ml of Doxicycline for 1, 2, 3, (qPCR) or 4 hours prior to downstream 469 
analyses.  470 
 471 
cDNA cloning of unannotated DUX4 targets 472 
Single human 4-cell embryo cDNA library was prepared according to the protocol by 473 
Tang et al.50 and used for cloning of the putative transcripts. The transcripts were 474 
amplified using Phusion High-Fidelity DNA polymerase (New England Biolabs) 475 
according to manufacturer’s instructions. Predicted KHDC1 pseudo gene 1, putative 476 
RING-finger type E3 ubiquitin ligase and putative RING-finger domain protein 477 
encoding genes were amplified using touchdown PCR: 98˚C for 30 s; 24 cycles of 478 
98˚C for 10 s, annealing for 30 s, temperature decreasing from 63˚C to 56˚C, 1 ˚C/3 479 
cycles, 72˚C for 30 s; 16 cycles of 98 ˚C for 10 s, 55˚C for 30 s, 72˚C for 30 s; final 480 
extension 72˚C for 10 min. All PCR products were cloned into pCR4Blunt-TOPO 481 
vector using Zero Blunt TOPO PCR Cloning kit (Invitrogen) and sequences were 482 
verified by Sanger sequencing (Eurofins Genomics). Clone sequences are available 483 
from the ENA browser at http://www.ebi.ac.uk/ena/data/view/LR694082-LR694089. 484 
 485 
Bioinformatics analysis and molecular dynamics simulations of the DUX4 protein 486 
The sequence for the human DUX4 (Q9UBX2) protein was obtained from the 487 
UniProt database (The UniProt Consortium30), whereas other sequences were 488 
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retrieved from the non-redundant database of NCBI using blastp51 and with human 489 
DUX4 as the query sequence. Multiple sequence alignment was carried out using 490 
MAFFT52. Secondary structures, solvent accessibility and disordered regions were 491 
predicted using POLYVIEW-2D53, SABLE54, SCRATCH55 and RaptorX-Property56. 492 
The 9aaTAD web server57 was used to predict 9aaTAD motifs. The 2.12 Å resolution 493 
crystal structure of the DUX4 HD1-linker-HD2 fragment bound to DNA19 (PDB: 494 
6E8C) was obtained from the Protein Data Bank58. PyMOL (version 1.6; Schrödinger 495 
LLC) and Bodil59 were used to analyze inter-HD interactions. Based on the DUX4 496 
structure, molecular dynamics (MD) simulations, over all atoms, were used to explore 497 
the dynamic states of the (1) double HD complex with (HD1-HD2 + DNA) and (2) 498 
without (HD1-HD2) bound DNA and the individual HDs with bound DNA: (3) HD1 499 
+ DNA and (4) HD2 + DNA. MD simulations of these four structures were carried 500 
out with the AMBER package60 (version 18) using the ff14SB61 (for protein) and 501 
OL1562 (for DNA) force fields. The structures were solvated with explicit TIP3P 502 
water molecules63 within an octahedral box ensuring a 12 Å distance between the 503 
boundaries of the simulation box and solute atoms. Sodium counter ions were added 504 
to neutralize the system and additional Na+/Cl- ions were added to bring the salt 505 
concentration to 150 mM. Periodic boundary conditions were employed and the 506 
particle-mesh Ewald algorithm64 was applied to electrostatic interactions with a 507 
distance cutoff of 9 Å.  508 
 509 
Prior to the production simulation, 5000 cycles of steepest descent and conjugate 510 
gradient energy minimization were carried out on each system, initiated by 511 
introducing a 25 kcal mol−1 Å−2 restraint on solute atoms that was gradually reduced 512 
to 0 kcal mol−1 Å−2 over the total minimization. The systems were then heated from 513 
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100 K to 300 K during 100 ps with a 10 kcal mol−1 Å−2 restraint on solute atoms, 514 
followed by a 900 ps equilibration at constant pressure while systematically reducing 515 
the restraint to 0.1 kcal mol−1 Å−2. The equilibration protocol was finalized with a 516 
restraint-free 5 ns simulation. The production simulation was performed for 100 ns at 517 
constant temperature (300 K) and pressure (1 bar), which was maintained using the 518 
Berendsen algorithm65 with 5 ps coupling constant. Trajectories were saved every 10 519 
ps and the resulting structural snapshots were analyzed further by calculating the root-520 
mean-square deviations (RMSD; over backbone atoms) and root-mean-square 521 
fluctuations (RMSF; over Cα atoms), as well monitoring hydrogen bond interactions 522 
using the programs CPPTRAJ66 and VMD67. 523 
 524 
Affinity purification of protein complexes, mass spectrometry and data analysis  525 
Cell Culture and Affinity Purification  526 
 527 
Cloning of DUX4 to MAC-tag Gateway® destination vector 528 
DUX4 was first amplified in two-step PCR reaction from pB-tight-DUX4-ires-529 
EmGFP-pA-PGK-Puro and cloned to Gateway compatible entry clone using Gateway 530 
BP Clonase II (Invitrogen) according to manufacturer’s instructions. The entry clone 531 
was further cloned to Gateway compatible destination vectors containing the C-532 
terminal and N-terminal tags as described21. Transfection and selection of the T-Rex 533 
293 cells (Invitrogen, Life Technologies, R78007, cultured in manufacturer’s 534 
recommended conditions) and affinity purification of the final product was done as 535 
previously21. 536 
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 537 
Liquid Chromatography-Mass Spectrometry 538 
Analysis was performed on a Q-Exactive mass spectrometer with an EASY-nLC 1000 539 
system via an electrospray ionization sprayer (Thermo Fisher Scientific), using 540 
Xcalibur version 3.0.63. Peptides were eluted from the sample with a C18 precolumn 541 
(Acclaim PepMap 100, 75 µm x 2 cm, 3 µm, 100 Å; Thermo Scientific) and 542 
analytical column (Acclaim PepMap RSLC, 65 µm x 15 cm, 2 µm, 100 Å; Thermo 543 
Scientific), using a 60 minute buffer gradient ranging from 5 to 35% Buffer B, then a 544 
5 min gradient from 35 to 80% Buffer B and 10 minute gradient from 80 to 100% 545 
Buffer B (0.1% formic acid in 98% acetonitrile and 2% HPLC grade water). 4 µl of 546 
peptide sample was loaded by a cooled autosampler. Data-dependent FTMS 547 
acquisition was in positive ion mode for 80 min. A full scan (200-2000 m/z) was 548 
performed with a resolution of 70,000 followed by top10 CID-MS2 ion trap scans with 549 
a resolution of 17,500. Dynamic exclusion was set for 30 s. Database search was 550 
performed with Proteome Discoverer 1.4 (Thermo Scientific) using the SEQUEST 551 
search engine on the Reviewed human proteome in UniProtKB/SwissProt databases 552 
(http://www.uniprot.org, downloaded Nov. 2018). Trypsin was selected as the 553 
cleavage enzyme and maximum of 2 missed cleavages were permitted, precursor 554 
mass tolerance at ±15 ppm and fragment mass tolerance at 0.05 Da. 555 
Carbamidomethylation of cysteine was defined as a static modification. Oxidation of 556 
methionine and biotinylation of lysine and N-termini were set as variable 557 
modifications. All reported data were based on high-confidence peptides assigned in 558 
Proteome Discoverer (FDR < 0.01).  559 
 560 
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Identification of statistical confidence of interactions 561 
Significance Analysis of INTeractome (SAINT68) -express version 3.6.3 and 562 
Contaminant Repository for Affinity Purification (CRAPome, 563 
http://www.crapome.org) were used to discover statistically significant interactions 564 
from the AP-MS data69. The DUX4 LC-MS data was ran alongside a large dataset of 565 
other transcription factors, as well as a large GFP control set. Final results represent 566 
proteins with a SAINT score higher than 0.73, and present in all four replicates.  567 
 568 
Overrepresentation Analysis 569 
Overrepresentation analysis of statistically significant interactions in Gene Ontology 570 
and Reactome was done in WebGestalt70, and overrepresentation of prey proteins in 571 
ComplexPortal71 (https://www.ebi.ac.uk/complexportal) and CORUM72 572 
(https://mips.helmholtz-muenchen.de/corum/) was done using Fisher’s exact test and 573 
multiple testing correction in an in-house R-script.  574 
 575 
Interaction network 576 
Protein interaction networks were constructed from filtered SAINT data that was 577 
imported to Cytoscape 3.6.0. Known prey-prey interactions were obtained from the 578 
iRef database (http://irefindex.org). 579 
 580 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/732289doi: bioRxiv preprint first posted online Aug. 12, 2019; 
 27 
RNA isolation, reverse transcription and quantitative real-time quantitative PCR  581 
Total RNA was isolated by NucleoSpin RNA kit (Macherey Nagel). 1µg of RNA was 582 
reverse transcribed by MMLV-RTase with oligodT, dNTPs, and Ribolock in MMLV-583 
RTase buffer (Thermo Fisher Scientific). 5X HOT FirelPol qPCR Mix (Solis 584 
Biodyne) was used to measure relative mRNA levels with Lightcycler (Roche). ΔΔ585 
CT method was followed to quantify relative gene expression where CYCLOPHILIN 586 
G was used as endogenous control. Relative expression of each gene was normalized 587 
to the expression without doxycycline treatment.  588 
 589 
Fluorescence associated cell sorting   590 
TetOn-DUX4 hESCs were treated with TrypLE for 5 min and suspended into cold 591 
FACS buffer (5% FBS-PBS). Single cell suspension was filtered through 40µm Cell 592 
strainers and centrifuged at 800 rpm for 5min. The cell pellets were suspended in cold 593 
FACS buffer and placed on ice. EmGFP- and EmGFP+ cells were separated to FACS 594 
buffer by Sony SH800Z Cell Sorter with blue laser (488) and 100 µm nozzle.  595 
 596 
ATAC-sequencing library preparation and data analysis  597 
In principle the ATAC-sequencing libraries were prepared as in73. 5x104 EmGFP-598 
negative and EmGFP-positive TetOn-hESCs for four biological samples; TetOn-599 
DUX4 in H1 clone 2, H1 clone 8, H9 clone 3 and H9 clone 4, were centrifuged at 600 
500g for 5 min. The pellets were washed in cold 1X PBS by centrifugation at 500g for 601 
5min. Each cell pellet was lysed in 50 µl of cold lysis buffer (10 mM Tris-HCl, pH 602 
7.4; 10 mM NaCl, 3 mM MgCl2, and 0.1% IGEPAL CA-630) and centrifuged at 500g 603 
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at 4°C for 10 min. The pellet was then resuspended in the transposase reaction mix 604 
(2.5 µl of transposase in TD buffer) and incubated at 37°C for 30min. The reactions 605 
were purified through columns and eluated in 20 µl. After addition of the barcode 606 
oligos the DNA samples were amplified for 12 cycles (98°C for 10 seconds, 63°C for 607 
30 seconds and 72°C for 60 seconds) in Phusion PCR master mix (Thermo Fisher 608 
Scientific).  The PCR products were purified through the columns and eluted in 20 µl.  609 
 610 
ATAC-seq data analysis  611 
Bcl files were converted and demultiplexed to fastq using the bcl2fastq program. 612 
STAR74 was used to index the human reference genome (hg19), obtained from 613 
UCSC, and align the resulting fastq files. The resulting bam files with the mapped 614 
reads were then converted to tag directories with subsequent peaks calling using the 615 
HOMER suit of programs48. HOMER was also employed for counting the reads in the 616 
identified peak regions. The raw tag counts from the peaks were then imported to 617 
R/Bioconductor and differential peak analysis was performed using the edgeR 618 
package and its general linear models pipeline. Peaks with an FDR adjusted p value 619 
under 0.05 were termed significant. Plotting was done in R using packages Complex 620 
heatmap, ggplot2 and ggbeeswarm. RepeatMasker table downloaded from UCSC 621 
(http://hgdownload.soe.ucsc.edu/goldenPath/hg19/database/rmsk.txt.gz) was 622 
converted to BED format and then intersected with the ATAC-seq peaks using the 623 
intersectBed from BEDTools46 to determine the peaks overlapped with ERVL-MaLR 624 
elements. ATAC-seq data of human early embryo were obtained from GSE10157130, 625 
and scores around the ATAC-seq peaks were calculated with computeMatrix and 626 
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visualized with plotHeatmap from deepTools47. All the scripts and command line 627 
options can be provided upon request. 628 
 629 
Immunocytochemistry of the human ESC  630 
The cells were fixed with 3.8% PFA, washed three times, permeabilised in 0.5% (v/v) 631 
Tx100-PBS for 7 min, and washed with washing buffer (0.1% (v/v) Tween20-PBS). 632 
The samples were incubated with ProteinBlock (Thermo Fisher Scientifi) at room 633 
temperature for 10 min to prevent unspecific binding of primary antibody. Primary 634 
antibody (rabbit MAb anti DUX4, clone E5-5, 1:400; Abcam) was diluted as 635 
indicated in washing buffer and incubated at 4°C overnight. After washings, 636 
fluorescence-conjugated secondary antibody (anti rabbit 594, A-21207; Thermo 637 
Fisher Scientific) was diluted 1:1000 in washing buffer and incubated at room 638 
temperature for 20 min. Nuclei were counterstained with DAPI 1:1000 in washing 639 
buffer. The images were captured with Evos FL Cell Imaging system with 10X and 640 
20X Plan Achromatic objectives.   641 
 642 
Immunocytochemistry of the human embryos  643 
The embryos were fixed in 3.8 % PFA at room temperature for 15min, washed three 644 
times in the washing buffer (above), and permeabilised in 0.5 % Tx100-PBS at room 645 
temperature for 15 min. Unspecific primary antibody binding was blocked as above. 646 
DUX4 (as above) was incubated at 4°C overnight. The embryos were washed and 647 
incubated in the secondary antibody (anti-rabbit 488, A-21202; Thermo Fisher 648 
Scientific) diluted 1:500 in washing buffer (as above) at room temperature for 2 649 
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hours. After washings, nuclei were counterstained with DAPI 1:500 in washing 650 
buffer.  651 
 652 
Imaging of the fixed human embryos  653 
The embryos were imaged in washing buffer on Ibidi 8-well μ slides with Leica TCS 654 
SP8 confocal laser scanning microscope (Leica Microsystems, Mannheim, Germany) 655 
using Leica HC PL APO CS2 40X/1.10NA and Leica HC PL APO CS2 63X/1.20NA 656 
water objectives.  657 
 658 
Confocal microscopy image analysis  659 
Confocal images were processed using Fiji (http://fiji.sc). For the data presented in 660 
the Fig 1b, images were smoothened by Gaussian filter (radius=1 pixel kernel). For 661 
the quantification of the DUX4 intensity in the nucleus (Fig 1c), the DAPI channel 662 
was denoised using rolling ball (radius=100). The images were smoothened in 3D 663 
using Gaussian filter (radius=2 pixel kernel) and cell nuclei were segmented. The 664 
segmented regions were used to measure average pixel intensity per nucleus in each 665 
cell in the DUX4 channel. DUX4 intensity in the nucleus was normalized to intensity 666 
of the corresponding cytoplasmic DUX4 staining in the single representative plane.  667 
 668 
Culture and microinjection of human embryos  669 
Human triploid zygotes were warmed using Gems Warming Set (Genea Biomedx) 670 
and cultured in G-TL medium (Vitrolife) in 6 %O2 and 6 % CO2 at 37°C. 12 µl of 671 
either 20 µM scrambled control siRNA (AM4611, Thermo Fisher Scientific) or 672 
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DUX4-targeting siRNA (cat. 4457308, Thermo Fisher Scientific) diluted in 673 
nucleotide-free H2O were mixed with total of 500 ng of GAP-GFP mRNA and 674 
centrifuged at maximum speed at 4°C for 10 min. The embryos were microinjected 675 
using Eppendorf microinjector and placed in G-TL medium in Geri dish for 3D time-676 
lapse imaging (Geri incubator, Genea Biomedx, Australia).  677 
 678 
Human embryo live imaging  679 
Imaging of the human triploid embryos was initiated immediately after 680 
microinjections (Geri incubator). Images were captured in 3D every 15 minutes until 681 
the embryos were removed for fluorescence staining or termination of the experiment.    682 
 683 
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Figure Legends  725 
Figure 1. DUX4 expression in human embryos.  726 
(a) Log2 RPM of DUX4 mRNA reads in human oocytes (N=20), zygotes (N=59), 2-727 
cell (N=4), 4-cell (N=14), and 8-cell (N=15) embryos.  728 
(b) Representative confocal images of zygotes (N=3), 2-cell (N=3), 4-cell (N=4), and 729 
8-cell (N=2) human embryos stained with monoclonal DUX4 antibody E5-5 (green). 730 
Nuclei counterstained with DAPI (magenta).  731 
(c) 3D quantification of DUX4 intensity in the nuclei of the human embryos, 732 
normalised to cytoplasmic DUX4 staining (single plane) with standard deviation.  733 
 734 
Figure 2. Structural features of DUX4.  735 
(a) Domain structure of full-length DUX4: N- and C-terminal amino acid residues, as 736 
well as boundary residues for the homeodomains HD1 and HD2, three predicted 737 
ordered C-terminal regions (disorder value < 0.5; red curve) and 9aaTAD motif 738 
(blue). Conservation of residues in primates versus the human sequence C-terminal to 739 
residue G153 (green curve) and sequence alignment and predicted secondary 740 
structures (alpha helices) of the ordered regions. Residue numbering from UniProt ID 741 
Q9UBX2.  742 
(b) Crystal structure (PDB:6E8C; Lee et al., 2018) of DUX4 HD1 (blue) and HD2 743 
(gold) in complex with the consensus DNA motif  “TAATCTAATCA” (grey). 744 
Disordered/linker regions, magenta; residues forming inter-homeodomain contacts 745 
drawn as sticks.  746 
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(c) Structure of DUX4 HD1 (blue) and 2 (gold) without DNA. The coordinates of the 747 
bound DNA of the X-ray structure shown in (b) were deleted from the coordinate file 748 
of DUX4 structure. Coloring as in (b).  749 
(d) View focused on the inter-homeodomain interactions shown in (c). Hydrogen 750 
bonds, yellow dash lines; coloring as in (b).  751 
(e) Sequence comparison of residues forming inter-homeodomain contacts.  752 
(f) Root-mean-squared fluctuations (RMSF) of the Cα atoms of the X-ray structure 753 
of DUX4 with (red curve) and without (blue curve) bound DNA during a 100 ns MD 754 
simulation. HD1 (blue), linker (magenta) and HD2 (gold).  755 
(g) Root-mean-squared deviation (RMSD) of the backbone atoms of the X-ray 756 
structure of DUX4 with and without bound DNA during a 100 ns MD simulation. 757 
Homedomains with (HD1-HD2 +DNA) and without (HD1-HD2) bound DNA and 758 
single homedomains (HD1+DNA and HD2 +DNA) with bound DNA were used in 759 
the simulations. 760 
 761 
Figure 3. The protein – protein interaction network of DUX4.  762 
(a) High confidence protein-protein interactions detected by AP-MS (n=24) and 763 
BioID (n=139) -methods (SAINT score > 0.74). Average spectral count of the 764 
interaction filtered to show interactions larger than the median (AP-MS=4.125, 765 
BioID=7.5).  766 
(b) DUX4 interactome, filtered to show spectral counts larger than median. BioID -767 
interactions shown in red lines and AP-MS -interactions in blue, if protein appeared in 768 
both data sets it is outlined in bold black. Known prey-prey interactions shown in grey 769 
(iREF). 770 
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 771 
Figure 4. Knockdown of DUX4 in human embryos.  772 
(a) Schematic of the experimental set up.  773 
(b) Human embryos immunostained with DUX4 antibody (green) 24 h after 774 
microinjection with either control siRNA (left panel) or DUX4 targeting siRNA (right 775 
panel). Nuclei counterstained with DAPI (blue). Overlay of a single representative z 776 
plane and the corresponding z-planes shown for DUX4 staining, nucleus and bright 777 
field channels on the right side of each overlay. Scale bar 50 µm.  778 
(c) Scatter plot of the expression levels of TFEs across the siCTRL and siDUX4 779 
embryos. Red dots represent significantly upregulated TFEs by siDUX4 and grey 780 
crosses represent TFEs, which showed no significant change.  781 
(d-f) TFEs upregulated (red dots) or showing no significant change (grey crosses) by 782 
siDUX4 in the human OET transcriptome as in3. Comparisons in d: oocyte to 4-cell, 783 
e: zygote to 4-cell, and f: 4-cell to 8-cell. The dotted line marks the cell division effect 784 
on cellular RNA content. P-values were calculated with Fisher’s exact test for the 785 
frequency of the siDUX4-upregulated TFEs of the TFEs normally downregulated 786 
during respective stages.  787 
(g) Expression levels of the oocyte-specific genes in siCTRL and siDUX4 embryos. 788 
Asterisks represent statistical significance (q-value < 0.05). Horizontal lines represent 789 
the median values in each group. 790 
 791 
Figure 5. Transcriptome and ChIP-seq analysis on the TetOn-DUX4 hESCs.  792 
(a) Schematic of the experimental set up.  793 
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(b) Doxicycline induction of TetOn-DUX4 hESCs induces expression of DUX4 and 794 
DUX4 target genes, ZSCAN4 and TRIM48. Shown for H1-TetOn-DUX4 clone 2. All 795 
clones selected for experiments followed the same trend. X-axis indicates time (h) 796 
incubated in doxycycline. Relative mRNA expression levels were normalized to the 797 
non-induced cells.  798 
(c) 4-hour doxycycline induction upregulates DUX4 protein expression in the 799 
nucleus, shown for H1-TetOn-DUX4 clone 2.  800 
(d) Proportion of the upregulated and downregulated TFEs based on the genome 801 
annotation.  802 
(e) Expression level of putative DUX4 target genes. Asterisks represent statistical 803 
significance (q-value < 0.05). Horizontal lines represent the median values in each 804 
group.  805 
(f) Proportion of the upregulated (Up), downregulated (Down), and non-significantly 806 
changed (NS) TFEs by DUX4 induction among the minor (Oocyte to 4-cell embryo) 807 
and major (4- to 8-cell embryo) EGA genes. One TFE out of the 129 major EGA 808 
genes annotated on unassigned chromosome (ChrUn) and was excluded from the 809 
analysis. 810 
(g) DUX4 ChIP-seq intensity26 around the peaks of reads within the upregulated TFEs 811 
(blue) and all the detected TFEs (green).  812 
(h) De novo motif enrichment analysis of the DUX4-induced TFEs. Top: the most 813 
significantly enriched motif (P = 1e-961). Bottom: the best-matched known motif 814 
(DUX4 ChIP-seq of myoblasts: GSE7579129; matched score = 0.92). 815 
(i) Enrichment analysis of the DUX4-induced TFEs with publicly available ChIP-seq 816 
datasets. A total of 7,216 ChIP-seq data for transcription factors are shown. ChIP-seq 817 
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data for DUX4 are shown in red. Dots on the left side of the dashed line are 818 
underrepresented, whereas dots on the right side are overrepresented.  819 
 820 
Figure 6. Novel DUX4 targets.  821 
(a) Predicted KHDC1 pseudogene 1 (clone K5.2), at chromosome 6 (73,918,461-822 
73,920,115) was expressed by the human 4-cell embryos (FE463525) and upregulated 823 
in the TetOn -DUX4- hESCs (TFE93242). TFEs overlapped with DUX4 binding sites 824 
(DUX4 ChIP). cDNA clone K5.2 (thick orange regions indicate exons and grey thin 825 
regions indicate introns) corresponded to the KHDC1 pseudogene 1 transcript 826 
assembly in TetOn-DUX4 cells. Transcript assemblies (mRNA Genbank and human 827 
ESTs), including unspliced, are shown.  828 
(b) Putative RING-finger type E3 ubiquitin ligase at chromosome 2 (108,273,771-829 
108,277,850) was expressed by the human 4-cell embryos (FE130507) and it was 830 
upregulated in the TetOn-DUX4 hESCs (TFE25640). DUX4 ChIP-seq peak 831 
overlapped with the TFEs. RET11.1 was cloned from human 4-cell embryo (clone 832 
RET11.1). Thick blue regions indicate exons and thin grey regions indicate introns. 833 
Transcript assemblies (mRNA Genbank and human ESTs), including unspliced, are 834 
shown. 835 
(c) Putative RING-finger domain protein at chromosome 8 (210,701-215,100) was 836 
expressed by the human 4-cell embryos (TFE533694) and induced by TetOn-DUX4 837 
hESCs (TFE102707). ChIP-seq overlapped with the TFEs. Two cDNA clones, Ring 838 
4.2 and Ring 10.22, were expressed in the human 4-cell embyos. Thick blue regions 839 
indicate exons and grey thin regions indicate introns. Transcript assemblies (mRNA 840 
Genbank and human ESTs), including unspliced, are shown.  841 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/732289doi: bioRxiv preprint first posted online Aug. 12, 2019; 
 39 
 842 
Figure 7. Integrated analysis of the DUX4 induced changes in the chromatin and 843 
transcriptome of the hESCs.  844 
(a) Heatmap of the 4,686 ATAC-sequencing reads across all samples at ATAC-seq 845 
peaks that overlap with differentially regulated TFE reads. Counts for each peak were 846 
standardized across each sample (mean=0, sd=1). Samples and peaks were then 847 
clustered using hierarchical clustering. The Separate heatmap of the ATAC-seq shows 848 
if the changes in the heatmap are significant (red: ATAC-reg gained; blue: ATAC-reg 849 
lost; grey: ATAC-reg non-significant). TFE-Reg heatmap shows if the overlapping 850 
TFE site is upregulated or downregulated (red: upregulated; blue: downregulated).  851 
(b) Quasi random plot showing the results of the differential peak analysis on the 852 
ATAC-seq and STRT-RNA-seq. Each point is an ATAC-seq peak. Analyses were 853 
carried out on peaks that were repeated at least three times. Red: ATAC-seq gained; 854 
blue: ATAC-seq lost; grey: ATAC-seq non-significant. Y-axis: The log fold change 855 
of the ATAC-seq reads in the DUX4 expressing versus the control samples. X-axis: 856 
The ATAC-seq peaks overlapping either with the down-regulated TFEs or 857 
upregulated TFEs.  858 
(c) Density plot showing distribution of the ATAC-seq peaks relative to the TSS of 859 
genes separated by how the peak is regulated by the DUX4-expression. red: ATAC-860 
reg gained; blue: ATAC-reg lost; grey: ATAC-reg non-significant.  861 
(d) Proportion of the peaks overlapped with ERVL-MaLR elements in the gained, 862 
non-significant and lost ATAC-reg peaks (pink) by DUX4 induction. Inset pie charts 863 
inidicate the proportion of the ATAC-gained peaks overlapping with DUX4 binding 864 
sites (green).  865 
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(e) ATAC-reg intensity of human early embryo30 around the gained, non-significant 866 
(NS), and lost ATAC-reg peaks by DUX4 induction which overlap with ERVL-867 
MaLR elements. 868 
 869 
  870 
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